This confirms that delivery of βPix/COOL-1-siRNA using the RGD-NP results in efficient tumour target gene knockdown in vivo (Figure 5B) and minor off-target effects in cortical astrocytes (Figure 5B). This evidence concerns the gene ARHGEF7 and neoplasm.